These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31373829)

  • 1. Targeting the Mitochondrial Potassium Channel Kv1.3 to Kill Cancer Cells: Drugs, Strategies, and New Perspectives.
    Prosdocimi E; Checchetto V; Leanza L
    SLAS Discov; 2019 Oct; 24(9):882-892. PubMed ID: 31373829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Kv1.3: a New Target in Cancer Biology?
    Checchetto V; Prosdocimi E; Leanza L
    Cell Physiol Biochem; 2019; 53(S1):52-62. PubMed ID: 31854954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines.
    Leanza L; O'Reilly P; Doyle A; Venturini E; Zoratti M; Szegezdi E; Szabo I
    Curr Pharm Des; 2014; 20(2):189-200. PubMed ID: 23701546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting a mitochondrial potassium channel to fight cancer.
    Leanza L; Venturini E; Kadow S; Carpinteiro A; Gulbins E; Becker KA
    Cell Calcium; 2015 Jul; 58(1):131-8. PubMed ID: 25443654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model.
    Severin F; Urbani A; Varanita T; Bachmann M; Azzolini M; Martini V; Pizzi M; Tos APD; Frezzato F; Mattarei A; Ghia P; Bertilaccio MTS; Gulbins E; Paradisi C; Zoratti M; Semenzato GC; Leanza L; Trentin L; Szabò I
    J Exp Clin Cancer Res; 2022 Feb; 41(1):64. PubMed ID: 35172855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mitochondrial Kv1.3-caveolin axis controls cell survival and apoptosis.
    Capera J; Pérez-Verdaguer M; Peruzzo R; Navarro-Pérez M; Martínez-Pinna J; Alberola-Die A; Morales A; Leanza L; Szabó I; Felipe A
    Elife; 2021 Jul; 10():. PubMed ID: 34196606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo.
    Leanza L; Romio M; Becker KA; Azzolini M; Trentin L; Managò A; Venturini E; Zaccagnino A; Mattarei A; Carraretto L; Urbani A; Kadow S; Biasutto L; Martini V; Severin F; Peruzzo R; Trimarco V; Egberts JH; Hauser C; Visentin A; Semenzato G; Kalthoff H; Zoratti M; Gulbins E; Paradisi C; Szabo I
    Cancer Cell; 2017 Apr; 31(4):516-531.e10. PubMed ID: 28399409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voltage-Gated Potassium Channels Kv1.3--Potentially New Molecular Target in Cancer Diagnostics and Therapy.
    Teisseyre A; Gąsiorowska J; Michalak K
    Adv Clin Exp Med; 2015; 24(3):517-24. PubMed ID: 26467143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells.
    Leanza L; Henry B; Sassi N; Zoratti M; Chandy KG; Gulbins E; Szabò I
    EMBO Mol Med; 2012 Jul; 4(7):577-93. PubMed ID: 22496117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells.
    Venturini E; Leanza L; Azzolini M; Kadow S; Mattarei A; Weller M; Tabatabai G; Edwards MJ; Zoratti M; Paradisi C; Szabò I; Gulbins E; Becker KA
    Neurosignals; 2017; 25(1):26-38. PubMed ID: 28869943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes.
    Gulbins E; Sassi N; Grassmè H; Zoratti M; Szabò I
    Biochim Biophys Acta; 2010; 1797(6-7):1251-9. PubMed ID: 20114030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Mitochondrial Ion Channels to Fight Cancer.
    Bachmann M; Costa R; Peruzzo R; Prosdocimi E; Checchetto V; Leanza L
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell metabolism: cancer's Achilles' heel.
    Kroemer G; Pouyssegur J
    Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Endocannabinoid System: A Target for Cancer Treatment.
    Laezza C; Pagano C; Navarra G; Pastorino O; Proto MC; Fiore D; Piscopo C; Gazzerro P; Bifulco M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of voltage-gated potassium channels to the regulation of apoptosis.
    Szabò I; Zoratti M; Gulbins E
    FEBS Lett; 2010 May; 584(10):2049-56. PubMed ID: 20102714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The voltage-gated potassium channel Kv1.3 is a promising multitherapeutic target against human pathologies.
    Pérez-Verdaguer M; Capera J; Serrano-Novillo C; Estadella I; Sastre D; Felipe A
    Expert Opin Ther Targets; 2016; 20(5):577-91. PubMed ID: 26634786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection.
    Varghese E; Samuel SM; Sadiq Z; Kubatka P; Liskova A; Benacka J; Pazinka P; Kruzliak P; Büsselberg D
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31226817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels.
    Leanza L; Zoratti M; Gulbins E; Szabò I
    Curr Med Chem; 2012; 19(31):5394-404. PubMed ID: 22856664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The secret life of ion channels: Kv1.3 potassium channels and proliferation.
    Pérez-García MT; Cidad P; López-López JR
    Am J Physiol Cell Physiol; 2018 Jan; 314(1):C27-C42. PubMed ID: 28931540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.